Showing results (101-110 of 301) with videos related to

Sort By:
Pageof 31
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2008
Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancerAlec C Kimmelman, Aram F Hezel, Andrew J Aguirre, et al.
Cancer|April 20, 2026
Phase 2 trial of exercise and low-dose ibuprofen for cancer-related cognitive impairment in patients receiving chemotherapyMichelle C Janelsins, Riham A Alieldin, Tyler Holler, et al.
Gut|August 20, 2021
GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunityLuis I Ruffolo, Katherine M Jackson, Peyton C Kuhlers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2010
Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients: kinetics and potential biomarker valueAndrew X Zhu, Dan G Duda, Marek Ancukiewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumorsAnna Berkenblit, Joseph P Eder, David P Ryan, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 31, 2020
Clinical staging in pancreatic adenocarcinoma underestimates extent of diseaseAkhil Chawla, Jennifer Wo, Carlos Fernandez-Del Castillo, et al.
The Oncologist|June 22, 2005
A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinomaAndrew X Zhu, Charles S Fuchs, Jeffrey W Clark, et al.
Clinical Colorectal Cancer|June 27, 2006
Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal cancerJeffrey A Meyerhardt, Denise Heseltine, Shuji Ogino, et al.
Cancer|July 13, 2002
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinomaCharles S Fuchs, Jeffrey W Clark, David P Ryan, et al.
Digestive Diseases and Sciences|July 26, 2006
A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumorsMatthew H Kulke, Bingyan Wu, David P Ryan, et al.
Pageof 31